Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

Infection and Immunity

Volumn 65, Issue 10, 1997, Pages 4038-4042

  Neisser, Andrea ^a   Bernheimer, Hans ^a   Berger, Thomas ^a   Moran, Anthony P ^b   Schwerer, Beatrix ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CHILD; CLINICAL ARTICLE; CROSS REACTION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STRAIN DIFFERENCE; SUBCLAVIAN STEAL SYNDROME;

EID: 0030863720     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.10.4038-4042.1997     Document Type: Article

References (31)

1. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33:241-249.
2. Aspinall, G. O., S. Fujimoto, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
3. Aspinall, G. O., A. G. McDonald. T. S. Raju, H. Pang. A. P. Moran, and J. L. Penner. 1993. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213:1017-1027.
4. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, L. A. Kurjanczyk, J. L. Penner, and A. P. Moran. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213: 1029-1037.
5. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, S. D. Mills, L. A. Kurjanczyk, and J. L. Penner. 1992. Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J. Bacteriol. 174:1324-1332.
6. Berlit, P., and J. Rakicky. 1992. The Miller Fisher syndrome: review of the literature. J. Clin. Neuro-Ophthal. 12:57-63.
7. Chiba, A., S. Kusunoki, T. Shimizu, and I. Kanazawa. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:677-679.
8. Chiba, A., S. Kusunoki, H. Obata, R. Machinami, and I. Kanazawa. 1993. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43:1911-1917.
9. Fisher, M. 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, areflexia). N. Engl. J. Med. 255:57-65.
10. Jacobs, B. C., H. P. Endtz, F. G. A. van der Meché, M. P. Hazenberg, H. A. M. Achtereekte, and P. A. van Doorn. 1995. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37:260-264.
11. Kuroki, S., T. Saida, M. Nukina, T. Haruta, M. Yosuioka, Y. Kobayashi, and H. Nakanishi. 1993. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
12. Mandrell, R. E., and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: host-modification of LOS. Immunobiology 187:382-402.
13. Moran, A. P., and D. T. O'Malley. 1995. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotox. Res. 2:233-235.
14. Moran, A. P., E. T. Rietschel, T. U. Kosunen, and U. Zähringer. 1991. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetyl-neuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173:618-626.
15. Obayashi, H., T. Saida, S. Kuroki, M. Nukina, and Y. Nishitani. 1993. Guillain-Barré syndrome and Campylobacter jejuni infection. Shinkei Naika 38:431-438.
16. Penner, J. L., J. N. Hennessy, and R. V. Congi. 1983. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2:378-383.
17. Rees, J. H., N. A. Gregson, P. L. Griffiths, and R. A. C. Hughes. 1993. Campylobacter jejuni and Guillain-Barré syndrome. Q. J. Med. 86:623-634.
18. Saito, M., N. Kasai, and R. K. Yu. 1985. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148:54-58.
19. 3. Infect. Immun. 64:2945-2949.
20. Schwerer, B., A. Neisser, R. J. Polt, H. Bernheimer, and A. P. Moran. 1995. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotox. Res. 2:395-403.
21. van der Meché, F. G. A., P. I. M. Schmitz, and the Dutch Guillain-Barré Study Group. 1992. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med. 326:1123-1129.
22. Willison, H. J., A. Almemar, J. Veitch, and D. Thrush. 1994. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 44:2395-2397.
23. Willison, H. J., and J. Veitch. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50:159-165.
24. Willison, H. J., J. Veitch, G. Paterson, and P. G. E. Kennedy. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56:204-206.
25. Yuki, N., S. Handa, T. Tai, M. Takahashi, K. Saito, Y. Tsujino, and T. Taki. 1995. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J. Neurol. Sci. 130:112-116.
26. Yuki, N., Y. Ichihashi, and T. Taki. 1995. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J. Neuroimmunol. 60:161-164.
27. Yuki, N., T. Taki, M. Takahashi, K. Saito, H. Yoshino, T. Tai, S. Handa, and T. Miyatake. 1994. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36:791-793.
28. Yuki, N., T. Taki, M. Takahashi, K. Saito, T. Tai, T. Miyatake, and S. Handa. 1994. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62:2101-2103.
29. Yuki, N., S. Sato, S. Tsuji, T. Ohsawa, and T. Miyatake. 1993. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43:414-417.
30. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178: 1771-1775.
31. Yuki, N., S. Handa, T. Taki, T. Kasama, M. Takahashi, K. Saito, and T. Miyatake. 1992. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13:451-453.